Altimmune, Inc. Common Stock (ALT) is a publicly traded Healthcare sector company. As of September 23, 2026, ALT trades at $3.26 with a market cap of $636.07M and a P/E ratio of -3.38. ALT moved -3.08% today. Year to date, ALT is -5.54%; over the trailing twelve months it is -13.89%. Its 52-week range spans $2.56 to $7.73. Analyst consensus is strong buy with an average price target of $19.50. Rallies surfaces ALT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ALT news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $3.26 |
| Market Cap | $636.07M |
| P/E Ratio | -3.38 |
| EPS | $-1.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.73 |
| 52-Week Low | $2.56 |
| Volume | 894.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $41.00K |
| Net Income | $-88.09M |
| Gross Margin | 0.00% |
6 analysts cover ALT: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.50.